Funding and Investments

Dec 16, 2013
BioPharm International
Caution should be taken when planning to crowdfund a biopharmaceutical startup.
Nov 01, 2013
BioPharm International
The JOBS Act and FDASIA show early signs of accelerating drug development.
Oct 01, 2013
BioPharm International
Early-stage companies are now embraced by buyers of new issues.
Aug 01, 2013
BioPharm International
By BioPharm International Editors
Pharmaceutical companies have stepped up gene therapy development in the wake of the approval of Glybera in 2012.
Jul 01, 2013
BioPharm International
Biotech companies raise most money in 13 years.
Apr 01, 2013
BioPharm International
Early-stage companies are finding alternatives to venture capital.
Jan 01, 2013
BioPharm International
A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.
Oct 01, 2012
BioPharm International
A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.
Jul 01, 2012
BioPharm International
Collaborative R&D models coincide with new ways to fund translational research.
Apr 01, 2012
BioPharm International
Better news about the global economy buoys life-sciences funding.
native1_300x100
lorem ipsum